Overseas expansion key for healthcare sector in 2019 and beyond: analysts
Having overseas entities will help firms manage in an increasingly competitive medical tourism market
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
WITH some exceptions, the healthcare sector was not spared the trade tensions and uncertainty that dogged equity markets throughout 2018.
Going forward, cost pressures and macroeconomic headwinds are expected to moderate prospects in 2019, but the long-term view is rosier, especially for companies with overseas operations. Analysts project a positive outlook beyond 2019 when recent regional expansions for players such as IHH Healthcare Bhd and Singapore Medical Group (SMG) will start to yield results, if handled successfully.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Singaporeans can now buy record amount of yen per Singdollar
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain